Reply to Zhou et al’s “Refining Psychosis Research: Insights on Cannabis Use and Data Accuracy”-Reference-Cited by-同舟云学术

Reply to Zhou et al’s “Refining Psychosis Research: Insights on Cannabis Use and Data Accuracy”

Published:2024-07-24 Issue:5 Volume:50 Page:965-967
ISSN:0586-7614
Container-title:Schizophrenia Bulletin
language:en
Short-container-title:

Author:

Brink Vera¹²^ORCID,Kirkbride James²^ORCID

Affiliation:

1. Department of Psychosis, University Center Psychiatry, University Medical Center Groningen, University of Groningen , Groningen , The Netherlands

2. PsyLife Group, Division of Psychiatry, University College London , London , UK

Funder

European Community’s Seventh Framework

São Paulo Research Foundation

University Medical Centre Groningen

National Institute for Health and Care Research

University College London Hospitals NHS Foundation Trust

UK Research and Innovation

Clinical Academic Research Partnership

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/schizophreniabulletin/article-pdf/50/5/965/58935831/sbae125.pdf

Reference14 articles.

1. The role of social deprivation and cannabis use in explaining variation in the incidence of psychotic disorders: findings from the EU-GEI Study;Brink;Schizophr Bull.,2024

2. Incident psychotic experiences following self-reported use of high-potency cannabis: results from a longitudinal cohort study;Hines;Addiction.,2024

3. Cannabis induced psychosis: a systematic review on the role of genetic polymorphisms;Carvalho;Pharmacol Res.,2022

4. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study;Di Forti;Lancet Psychiatry.,2015

5. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study;Zammit;BMJ.,2002